title: Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantation.
authors.affiliation: Department of Surgery, Charité, Virchow-Klinikum, Humboldt-University Berlin, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Pfitzmann
authors.forename: J
authors.initials: J
authors.lastname: Klupp
authors.forename: J M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: G
authors.initials: G
authors.lastname: Junge
authors.forename: U
authors.initials: U
authors.lastname: Settmacher
authors.forename: T
authors.initials: T
authors.lastname: Steinmüller
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D019703:Calcineurin / Q000009:adverse effects; D065095:Calcineurin Inhibitors; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000145:classification / Q000276:immunology; D012189:Retrospective Studies
chemical_list: D065095:Calcineurin Inhibitors; D019703:Calcineurin; D009173:Mycophenolic Acid